Technology News and Research

RSS

New shoulder pad technology allows quicker access to injured players

Riddell today unveiled a new shoulder pad technology that could significantly improve the way in which spine and head injuries can be treated on the football field. The Riddell RipKord is being featured at the National Athletic Trainer's Association (NATA) 62nd Annual Meeting & Clinical Symposia this week in New Orleans.

20 Jun 2011

Valencell receives $5.5M in Series B venture investment

Valencell, an innovator in mobile health and fitness technology, announced today that it has received $5.5 million in Series B venture investment. The round was led by Best Buy Capital, the investment group of Best Buy Co., Inc., with participation from Series A investors TDF and True Ventures.

20 Jun 2011

Medidata to acquire Clinical Force

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that it has entered into a definitive agreement to acquire Clinical Force, a pioneer in providing SaaS-based clinical trial management systems (CTMS), for undisclosed proceeds.

20 Jun 2011

Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced the launch of iSPERSE, the company's novel inhaled dry powder drug delivery platform.

20 Jun 2011

DATATRAK expands and rebrands unified software suite

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the expansion and rebranding of their unified software suite as DATATRAK ONE.

20 Jun 2011

Teleflex, Amerinet sign deal for VasoNova Vascular Positioning System

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova Vascular Positioning System to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.

20 Jun 2011

WellAWARE Systems announces new partnership with Masonic Homes of Kentucky

WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced a new partnership with Masonic Homes of Kentucky.

20 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Concert to advance CTP-499, C-21191 into Phase 2 trials for diabetic nephropathy and spasticity

Concert Pharmaceuticals, Inc. announced today the advancement of two programs from its DCE Platform. CTP-499 is progressing into Phase 2 clinical trials for diabetic nephropathy and C-21191 has been selected as a lead candidate for spasticity.

20 Jun 2011

Premier healthcare honors Toshiba with Supplier Performance Award

Toshiba America Medical Systems, Inc. today announced that it is a winner of the sixth annual Performance Award, presented by the Premier healthcare alliance.

20 Jun 2011

Novel biomarker-development pipeline approach for human diseases

Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans.

20 Jun 2011

European Patent Office issues notice of allowance to Kuros' synthetic biomaterials

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today the allowance of European Patent Application 00910049 by the European Patent Office.

20 Jun 2011

NIH-funded study to develop virtual reality simulator for 'scarless' endoscopic surgery

Researchers at Rensselaer Polytechnic Institute have secured a $2.7 million grant to develop the first-ever virtual reality simulator for next-generation "scarless" endoscopic surgery.

20 Jun 2011

Veritract to develop 'Smart Feeding Tube' with live camera and steering mechanism

Feeding tubes are not as harmless as they seem. Every year in the U.S. over 40,000 feeding tubes are mistakenly placed into a patient's lungs, which results in an estimated 6,000 deaths. But a University of Utah startup company, Veritract Inc., hopes to end these risks by making the placement of feeding tubes much safer and faster.

20 Jun 2011

Genomic study identifies MCU that regulates calcium transport into mitochondria

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Massachusetts General Hospital (MGH), the Broad Institute, and the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), today announced new findings published in Nature.

20 Jun 2011

Australian Government announces new tax credit system for R&D activities

Providing a valuable incentive for U.S. investment in Australia, the Australian Government announced an agreement under which the Parliament will enact a AU$1.8 billion R&D tax credit that will deliver funding to innovative firms in industries including advanced manufacturing, information and communications technologies, and biotechnology.

18 Jun 2011

Patients still being enrolled in clinical trial for new peripheral vascular disease treatment

The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, reports the University of Louisville surgeon who is the principal investigator.

18 Jun 2011

Technology aids in maintaining quality of life in aging

Dorothy Rutherford is anxiously typing at her home computer, filling in answers to an online spelling game. Gerontologists say aging in place vastly improves the quality of life for seniors and is a lot cheaper for society than group homes and institutions.

18 Jun 2011

GenMark prices public offering of common stock

GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.

17 Jun 2011